According to the announcement the 180 day PMA review period will be re-entered with 90 days left to go once AVH respond to the FDA. In other words, the clock was stopped at day 90, which is before day 100 and by my reckoning, counting back from 27th December, was Friday 29th September. Therefore, I don't think they were aware of this before the Cantor presentation.
I'm hopeful that it is just a minor hardware issue to be resolved.
Be it as it may, it doesn't reduce the growing demand for Recell or prevent the continued increase in sales of the Recell kits for use via the conventional preparation.
Ann: Form 8-K, page-43
-
- There are more pages in this discussion • 87 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.78 |
Change
0.280(11.2%) |
Mkt cap ! $190.5M | |||
| Open | High | Low | Value | Volume |
| $2.51 | $2.80 | $2.51 | $1.289M | 483.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 934 | $2.76 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.78 | 2232 | 3 |
View Market Depth
| Last trade - 11.47am 09/08/2024 (20 minute delay) ? |
| AVH (ASX) Chart |